RE:RE:INTERESTING ARTICLE RE cholesterol EFFLUX AS MEASURE OF HDL It would be nice if RVX would put this information on their blog so the rest of there shareholders might no some more information. It amazes me why management are so secretive and scare about relaying shareholder info yet they don't understand why the shareprice is where it is at
What would be the market cap of any normal smal biotech for a diabetes drug develpment co going into a phase 3 trial with no safety issues to date, and having the MACE # they have from the past 2 trials. 75 million, ?? 250 million 500 million ??? why is shareholder value so low for a small molecule compound with such huge potential.(assuming a positive phase 3 trial) Something is not adding up!!